Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) SVB Securities Global Biopharma Conference February 14, 2023 9:20 AM ET Company Participants Ryan Crowe - VP, IR Izzy Lowy - SVP of Clinical Development for Oncology Andres Sirulnik - SVP, Translational & Clinical Sciences, Hematology Conference Call Participants David Risinger - SVB Securities David Risinger So good morning, everybody, and thank you for joining our session with Regeneron. My name is Dave Risinger. I'm responsible for diversified biopharmaceutic ...